Related Experiment Video
Updated: Nov 25, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Outcomes of COVID-19 Among Hospitalized Patients With Non-dialysis CKD
Armando Coca1,2, Carla Burballa2,3, Francisco Javier Centellas-Pérez2,4
1Department of Nephrology, Hospital Clínico Universitario Valladolid, Valladolid, Spain.
Insights
Patients with chronic kidney disease (CKD) hospitalized for COVID-19 face significantly higher risks of death and acute kidney injury (AKI). This highlights the vulnerability of CKD patients during the COVID-19 pandemic.
Area of Science:
- Nephrology
- Infectious Diseases
- Critical Care Medicine
Background:
- Coronavirus disease 2019 (COVID-19) poses a global health threat, potentially causing pneumonia and organ damage.
- While prior epidemics suggest increased mortality for chronic kidney disease (CKD) patients, specific risks for non-dialysis CKD individuals with COVID-19 remain understudied.
Purpose of the Study:
- To evaluate the risks of mortality and acute kidney injury (AKI) in non-dialysis CKD patients hospitalized with COVID-19 compared to matched controls.
Main Methods:
- A multicenter, observational cohort study included 136 non-dialysis CKD patients and 136 age/sex-matched controls hospitalized for COVID-19.
- Exclusion criteria included end-stage renal disease, kidney transplant, or lack of baseline glomerular filtration rate.
- CKD and AKI were defined using KDIGO criteria.
Main Results:
- CKD patients exhibited higher white blood cell counts and D-dimer levels, and lower lymphocyte percentages.
- CKD was associated with substantially higher rates of AKI (61% vs. 24.3%) and mortality (40.4% vs. 24.3%).
- Patients with AKI had the highest hazard for death, followed by CKD patients without AKI.
Conclusions:
- Hospitalization for COVID-19 significantly increases the risk of mortality and AKI in non-dialysis CKD patients.
- CKD status did not influence ICU admission or length of hospital stay.
Abstract:
Background: Coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome-Corona Virus 2 has generated significant impact on global health worldwide. COVID-19 can cause pneumonia and organ injury. Chronic kidney disease (CKD) has been associated with increased mortality in previous epidemics, but there is a paucity of data regarding actual risks for non-dialysis CKD patients with COVID-19. Methods: Multicenter, observational cohort study including 136 non-dialysis CKD patients and 136 age- and sex-matched controls that required hospitalization due to COVID-19. Patients with end-stage renal disease, a kidney transplant or without registered baseline glomerular filtration rate prior to COVID-19 infection were excluded. CKD and acute kidney injury (AKI) were defined according to KDIGO criteria. Results: CKD patients had higher white blood cell count and D-dimer and lower lymphocyte percentage. No differences were found regarding symptoms on admission. CKD was associated with higher rate of AKI (61 vs. 24.3%) and mortality (40.4 vs. 24.3%). Patients with AKI had the highest hazard for death (AKI/non-CKD HR:7.04, 95% CI:2.87-17.29; AKI/CKD HR:5.25, 95% CI: 2.29-12.02), followed by CKD subjects without AKI (HR:3.39, 95% CI:1.36-8.46). CKD status did not condition ICU admission or length of in-hospital stay. Conclusions: CKD patients that require hospitalization due to COVID-19 are exposed to higher risk of death and AKI.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease I: Introduction

